Mergers & Acquisitions


Current filters:


Popular Filters

710 to 734 of 921 results

Valeant may pull out of Russian Natur Produkt acquisition


According to local sources in Russia, acquisitive Canadian drugmaker Valeant Pharmaceuticals (TSX: VRX)…

Mergers & AcquisitionsNatur ProduktPharmaceuticalValeant Pharmaceuticals

TPG completes $1.9 billion acquisition of Par Pharma


Par Pharmaceuticals (NYSE: PRX), a USA-based maker of generic drugs and niche innovative proprietary…

GenericsMergers & AcquisitionsPar PharmaceuticalsTPG

Russia's Maxwell Biotech Venture Fund invests in Osteros Biomedica


Earlier this month, the investment committee of Maxwell Biotech Venture Fund (MBVF), founded with the…

BiotechnologyMaxwell BiotechMBC PharmaMBC-11Mergers & AcquisitionsOncologyOsteros BiomedicaResearch

Valeant Pharma acquires Visudyne from QLT


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) said yesterday that it…

Mergers & AcquisitionsOphthalmicsPharmaceuticalQLTValeant PharmaceuticalsVisudyne

Colby Pharma acquires Othera


Colby Pharmaceutical, a privately held California-based biopharmaceutical company, says that it has acquired…

Colby PharmaceuticalMergers & AcquisitionsOthera PharmaceuticalsPharmaceutical

Illumina acquires UK's BlueGnome


US developer, manufacturer and marketer of life science tools and integrated systems for the analysis…

BlueGnomeIlluminaMergers & AcquisitionsPharmaceutical

Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam


Emerging markets, BRIC countries are words that have recently risen to prominence in a majority of pharmaceutical…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalSanofiSouth America

Johnson & Johnson to set up innovation centers to accelerate partnering


US health care giant Johnson & Johnson (NYSE: JNJ) yesterday said it plans to establish four regional…

Johnson & JohnsonLicensingMergers & AcquisitionsPharmaceuticalResearch

Bionomics buys US cancer stem cell firm Eclipse Therapeutics


Australian biotech firm Bionomics (ASX: BNO) has expanded its presence in the USA with the acquisition…

BionomicsBiotechnologyEclipse TherapeuticsMergers & AcquisitionsOncology

Pfizer launches generics JV in China with Hisun


Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceuticals (SSE Code: 600267), a leading…

Asia-PacificGenericsHisun-PfizerMergers & AcquisitionsPfizerPharmaceuticalZhejiang Hisun Pharma

Japan's vulnerable pharma companies, by P Reed Maurer


Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

Jazz Pharma sells women's health business to Meda for $95 million


US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's…

Jazz PharmaceuticalsMedaMergers & AcquisitionsPharmaceuticalWomen's Health

Valeant on the prowl again, with bid to buy Medicis for about $2.6 billion


In a sixth acquisition so far this year, as well as several takeovers the previous year, Canada's Valeant…

DermatologicalsMedicis PharmaceuticalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Mitsubishi Tanabe to take full control of Bipha JV


Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has agreed to acquire the 49% holding (20,580…

Bipha CorpMergers & AcquisitionsMitsubishi TanabePharmaceutical

Synergy Pharma gains rights to shingles drug from Bristol-Myers


US biopharma firm Synergy Pharmaceuticals (Nasdaq: SGYP) has signed an asset purchase agreement with…

Anti-viralsBiotechnologyBristol-Myers SquibbFV-100Mergers & AcquisitionsSynergy Pharmaceuticals

710 to 734 of 921 results

Back to top